Telomir Pharmaceuticals, Inc. (TELO) Stock Forecast & Price Target
TELO Analyst Ratings
TELO Stock 12 Month Forecast
Average Price Target
$4.00▲(327.81% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | $4 | buy | 327.81%Upside | Initiated | 09/17/26 | ||
| Michael King | Rodman & Renshaw | $8 | buy | 755.61%Upside | Initiated | 01/13/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | 09/17/26 | $4 | buy | 327.81%Upside | Initiated | Maxim Group | ||
| Michael King | 01/13/26 | $8 | buy | 755.61%Upside | Initiated | Rodman & Renshaw |
Best Analysts Covering Telomir Pharmaceuticals, Inc.
Copying Michael King's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -2.20% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.90% per trade.
Copying Jason McCarthy's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -12.90% per trade.
TELO Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 1 | 1 |
In the current month, TELO has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TELO average Analyst price target in the past 3 months is 4.00.
TELO Financial Forecast
TELO Earnings Forecast
Next quarter’s earnings estimate for TELO is -$0.57 with a range of ― to ―. The previous quarter’s EPS was ―. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.